What is Medifast's stock-based comp?

Medifast (MED) reported stock-based comp of $1.9M in Q1 2026.

How has Medifast's stock-based comp changed year-over-year?

Medifast's stock-based comp decreased by 1.8% year-over-year, from $1.93M to $1.9M.

What is the long-term trend for Medifast's stock-based comp?

Over 4 years (2021 to 2025), Medifast's stock-based comp has grown at a -6.2% compound annual growth rate (CAGR), from $9.89M to $7.64M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Medifast MED Stock-Based Comp

Stock-Based Comp at other companies

Eli LillyLLY

$161M+4.5%

WW International, Inc.WW

$391K-54.5%

HerbalifeHLF

$10.6M-8.6%

Omada Health, Inc. Common StockOMDA

$4.21M+48.0%

Lifevantage CorporationLFVN

$704K-53.7%

The Beachbody CompanyBODI

$1.12M-35.2%

Segments

By segment

See full

Optavia Segment$1.9M-1.8%

Other financials

Income statement

See full

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

See full

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

See full

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

See full

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

See full

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

See full

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Medifast's stock-based comp?: Medifast (MED) reported stock-based comp of $1.9M in Q1 2026.
How has Medifast's stock-based comp changed year-over-year?: Medifast's stock-based comp decreased by 1.8% year-over-year, from $1.93M to $1.9M.
What is the long-term trend for Medifast's stock-based comp?: Over 4 years (2021 to 2025), Medifast's stock-based comp has grown at a -6.2% compound annual growth rate (CAGR), from $9.89M to $7.64M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.